{"PubmedBookArticle": [], "PubmedArticle": [{"MedlineCitation": {"KeywordList": [["ECE1", "PPARG", "allelic variants", "osteoporosis", "polymerase chain reaction"]], "OtherAbstract": [], "SpaceFlightMission": [], "InvestigatorList": [], "CitationSubset": [], "OtherID": [], "GeneralNote": [], "PMID": "39062013", "DateRevised": {"Year": "2024", "Month": "07", "Day": "29"}, "Article": {"Language": ["eng"], "ELocationID": ["1440", "10.3390/biomedicines12071440"], "ArticleDate": [{"Year": "2024", "Month": "06", "Day": "27"}], "Journal": {"ISSN": "2227-9059", "JournalIssue": {"Volume": "12", "Issue": "7", "PubDate": {"Year": "2024", "Month": "Jun", "Day": "27"}}, "Title": "Biomedicines", "ISOAbbreviation": "Biomedicines"}, "ArticleTitle": "The Analysis of ECE1 and PPARG Variants in the Development of Osteopenia and Osteoporosis in Postmenopausal Women.", "Abstract": {"AbstractText": ["Osteoporosis is a multifactorial systemic skeletal disease that is characterized by a low bone mineral density (BMD) and the microarchitectural deterioration of bone tissue, leading to bone fragility. The search for new genes that may play an important role in the regulation of bone mass and the development of osteoporosis is ongoing. Recently, it was found that altering the activity of the endothelin-1-converting enzyme encoded by the <i>ECE1</i> gene may affect bone mineral density (BMD). Another gene involved in the process of osteoblast differentiation and maturation is believed to be <i>PPARG</i> (peroxisome proliferator-activated receptor gamma). This participates in regulating the transformation of stem cells and affects the process of bone formation and resorption. Therefore, we analyzed the association of the <i>ECE1</i> and <i>PPARG</i> variants with osteopenia and osteoporosis risk in the Polish population. This study included a group (<i>n</i> = 608) of unrelated Polish women (245 individuals with osteoporosis (aged: 57 \u00b1 9), 109 individuals with osteopenia (aged: 53 \u00b1 8) and 254 healthy controls (aged: 54 \u00b1 8)). The real-time PCR technique was used to determine the genetic variants for rs213045 (-338<i>G</i>><i>T</i>) and rs213046 (-839<i>A</i>><i>C</i>) of the <i>ECE1</i> gene and rs1801282 (Pro12Ala, <i>C</i>><i>G</i>) of the <i>PPARG</i> gene. Analysis of the <i>PPARG</i> rs1801282 variants did not show any association with the risk of osteoporosis and osteopenia. However, in the densitometric results, lower median Z-score values were observed for the <i>T</i> allele compared to the <i>G</i> allele for the rs213045 variant of the <i>ECE1</i> gene (-1.11 \u00b1 1.07 vs. -0.78 \u00b1 1.21, <i>p</i> = 0.021). Moreover, the <i>TT</i> genotype for the rs213045 variant was more common in women with osteopenia (13.8%, OR = 2.82, <i>p</i> < 0.05) and osteoporosis (7.8%, OR = 1.38, <i>p</i> > 0.05) compared to the control group (5.5%). Additionally, our results suggested that the T allele of rs213045 was more common in women with osteopenia compared to the controls. We further observed that the haplotype containing two major <i>GA</i> alleles of <i>ECE1</i> (rs213045, rs213046) could reduce the risk of osteopenia in our population. Finally, we found that women with osteoporosis had statistically significantly lower body mass and BMI values compared to the control group. Our results suggest that the <i>ECE1</i> rs213045 variant may increase the risk of osteopenia. However, the data obtained require confirmation in further studies."]}, "AuthorList": [{"Identifier": [], "AffiliationInfo": [{"Identifier": [], "Affiliation": "Department of General Pharmacology and Pharmacoeconomics, Pomeranian Medical University in Szczecin, \u017bo\u0142nierska 48, 71-230 Szczecin, Poland."}, {"Identifier": [], "Affiliation": "Department of Pharmacology and Toxicology, Institute of Health Sciences, Collegium Medicum, University of Zielona G\u00f3ra, Zyty 28, 65-048 Zielona G\u00f3ra, Poland."}], "LastName": "Uzar", "ForeName": "Izabela", "Initials": "I"}, {"Identifier": ["0000-0001-5455-8315"], "AffiliationInfo": [{"Identifier": [], "Affiliation": "Department of Personalized Medicine and Cell Therapy, Regional Blood Center, Marcelinska 44, 60-354 Poznan, Poland."}], "LastName": "Bogacz", "ForeName": "Anna", "Initials": "A"}, {"Identifier": [], "AffiliationInfo": [{"Identifier": [], "Affiliation": "Department of Stem Cells and Regenerative Medicine, Institute of Natural Fibres and Medicinal Plants, Kolejowa 2, 62-064 Plewiska, Poland."}], "LastName": "\u0141uszczy\u0144ska", "ForeName": "Ma\u0142gorzata", "Initials": "M"}, {"Identifier": [], "AffiliationInfo": [{"Identifier": [], "Affiliation": "Department of Stem Cells and Regenerative Medicine, Institute of Natural Fibres and Medicinal Plants, Kolejowa 2, 62-064 Plewiska, Poland."}], "LastName": "Wolek", "ForeName": "Marlena", "Initials": "M"}, {"Identifier": ["0000-0002-1391-4499"], "AffiliationInfo": [{"Identifier": [], "Affiliation": "Department of General and Dental Radiology, Pomeranian Medical University in Szczecin, Powsta\u0144c\u00f3w Wielkopolskich 72, 70-111 Szczecin, Poland."}], "LastName": "Kotrych", "ForeName": "Katarzyna", "Initials": "K"}, {"Identifier": [], "AffiliationInfo": [{"Identifier": [], "Affiliation": "Clinical Department of General Surgery, Pomeranian Medical University in Szczecin, Piotra Skargi 9-11, 70-965 Szczecin, Poland."}], "LastName": "Modrzejewski", "ForeName": "Andrzej", "Initials": "A"}, {"Identifier": [], "AffiliationInfo": [{"Identifier": [], "Affiliation": "Department of General Pharmacology and Pharmacoeconomics, Pomeranian Medical University in Szczecin, \u017bo\u0142nierska 48, 71-230 Szczecin, Poland."}, {"Identifier": [], "Affiliation": "Department of Stem Cells and Regenerative Medicine, Institute of Natural Fibres and Medicinal Plants, Kolejowa 2, 62-064 Plewiska, Poland."}], "LastName": "Czerny", "ForeName": "Bogus\u0142aw", "Initials": "B"}, {"Identifier": [], "AffiliationInfo": [{"Identifier": [], "Affiliation": "Department of Orthopaedics, Traumatology and Orthopaedic Oncology, Pomeranian Medical University in Szczecin, Unii Lubelskiej 1, 71-252 Szczecin, Poland."}], "LastName": "Zi\u0119tek", "ForeName": "Pawe\u0142", "Initials": "P"}, {"Identifier": [], "AffiliationInfo": [{"Identifier": [], "Affiliation": "Department of Orthopedics and Traumatology, Independent Public Clinical Hospital No. 1, Pomeranian Medical University in Szczecin, Unii Lubelskiej 1, 71-252 Szczecin, Poland."}], "LastName": "Kami\u0144ski", "ForeName": "Adam", "Initials": "A"}], "PublicationTypeList": ["Journal Article"]}, "MedlineJournalInfo": {"Country": "Switzerland", "MedlineTA": "Biomedicines", "NlmUniqueID": "101691304", "ISSNLinking": "2227-9059"}, "CoiStatement": "The authors declare no conflicts of interest."}, "PubmedData": {"ReferenceList": [{"ReferenceList": [], "Reference": [{"Citation": "Ji M.-X., Yu Q. Primary osteoporosis in postmenopausal women. Chronic Dis. Transl. Med. 2015;21:9\u201313.", "ArticleIdList": ["PMC5643776", "29062981"]}, {"Citation": "Mu\u00f1oz M., Robinson K. Bone health and osteoporosis prevention and treatment. Clin. Obs. Gynecol. 2020;63:770\u2013787. doi: 10.1097/GRF.0000000000000572.", "ArticleIdList": ["10.1097/GRF.0000000000000572", "33017332"]}, {"Citation": "Pouresmaeili F., Kamalidehghan B., Kamarehei M., Goh Y.M. A comprehensive overview on osteoporosis and its risk factors. Ther. Clin. Risk Manag. 2018;14:2029\u20132049. doi: 10.2147/TCRM.S138000.", "ArticleIdList": ["10.2147/TCRM.S138000", "PMC6225907", "30464484"]}, {"Citation": "Kragl A., Hannemann A., Nauck M., V\u00f6lker U., Siggelkow H., Teumer A., Tzvetkov M.V. Genetic Variants in WNT16 and PKD2L1 Locus Affect Heel Ultrasound Bone Stiffness: Analyses from the General Population and Patients Evaluated for Osteoporosis. Calcif. Tissue Int. 2023;113:540\u2013551. doi: 10.1007/s00223-023-01141-9.", "ArticleIdList": ["10.1007/s00223-023-01141-9", "PMC10618371", "37831088"]}, {"Citation": "Wolski H., Bogacz A. Polymorphism of bone morphogenetic protein (BMP2) and osteoporosis etiology. Ginekol. Pol. 2015;86:203\u2013209. doi: 10.17772/gp/2006.", "ArticleIdList": ["10.17772/gp/2006", "25920311"]}, {"Citation": "Kaleta B., Walicka M. Toll-Like Receptor 4 Gene Polymorphism C1196T in Polish Women with Postmenopausal Osteoporosis\u2014Preliminary Investigation. Adv. Clin. Exp. Med. 2015;24:239\u2013243. doi: 10.17219/acem/22747.", "ArticleIdList": ["10.17219/acem/22747", "25931355"]}, {"Citation": "Wolski H., Drw\u0119ska-Matelska N. The role of Wnt/\u03b2-catenin pathway and LRP5 protein in metabolism of bone tissue and osteoporosis etiology. Ginekol. Pol. 2015;86:311\u2013314. doi: 10.17772/gp/2079.", "ArticleIdList": ["10.17772/gp/2079", "26117992"]}, {"Citation": "Jin H., Evangelou E. Polymorphisms in the 5\u2019 flank of COL1A1 gene and osteoporosis: Meta-analysis of published studies. Osteoporos. Int. 2011;22:911\u2013921. doi: 10.1007/s00198-010-1364-5.", "ArticleIdList": ["10.1007/s00198-010-1364-5", "PMC4696542", "20798928"]}, {"Citation": "Mohammadi Z., Fayyazbakhsh F. Association between vitamin D receptor gene polymorphisms (Fok1 and Bsm1) and osteoporosis: A systematic review. J. Diabetes Metab. Disord. 2014;13:98. doi: 10.1186/s40200-014-0098-x.", "ArticleIdList": ["10.1186/s40200-014-0098-x", "PMC4215021", "25364703"]}, {"Citation": "Hansen K.E., Johnson M.G., Carter T.C., Mayer J., Keuler N.S., Blank R.D. The -839(A/C) Polymorphism in the ECE1 Isoform b Promoter Associates with Osteoporosis and Fractures. J. Endocr. Soc. 2019;15:2041\u20132050. doi: 10.1210/js.2019-00057.", "ArticleIdList": ["10.1210/js.2019-00057", "PMC6795020", "31637345"]}, {"Citation": "Funalot B., Courbon D., Brousseau T., Poirier O., Berr C., Cambien F., Amouyel P., Schwartz J.C., Ducimeti\u00e8re P., EVA Study Genes encoding endothelin-convertingenzyme-1 and endothelin-1 interact to influence blood pressure in women: The EVA study. J. Hypertens. 2004;22:739\u2013743. doi: 10.1097/00004872-200404000-00016.", "ArticleIdList": ["10.1097/00004872-200404000-00016", "15126915"]}, {"Citation": "Dalgic S.N., Yilmaz Aydogan H., Ozturk O., Pence S., Kanca Demirci D., Abaci O., Kocas C., Dalgic Y., Bostan C., Yildiz A. Effects of ECE-1b rs213045 and rs2038089 polymorphisms on the development of contrast-induced acute kidney injury in patients with acute coronary syndrome. J. Int. Med. Res. 2020;48:0300060519886987. doi: 10.1177/0300060519886987.", "ArticleIdList": ["10.1177/0300060519886987", "PMC7607270", "31777301"]}, {"Citation": "Sin A., Tang W., Wen C.Y., Chung S.K., Chiu K.Y. The emerging role of endothelin-1 in the pathogenesis of subchondral bone disturbance and osteoarthritis. Osteoarthr. Cartil. 2015;23:516\u2013524. doi: 10.1016/j.joca.2014.11.002.", "ArticleIdList": ["10.1016/j.joca.2014.11.002", "25463446"]}, {"Citation": "Lecka-Czernik B. PPAR\u03b3, an Essential Regulator of Bone Mass: Metabolic and Molecular Cues. IBMS Bonekey. 2010;7:171\u2013181. doi: 10.1138/20100443.", "ArticleIdList": ["10.1138/20100443"]}, {"Citation": "Baroi S., Czernik P.J., Chougule A., Griffin P.R., Lecka-Czernik B. PPARG in osteocytes controls sclerostin expression, bone mass, marrow adiposity and mediates TZD-induced bone loss. Bone. 2021;147:115913. doi: 10.1016/j.bone.2021.115913.", "ArticleIdList": ["10.1016/j.bone.2021.115913", "PMC8076091", "33722775"]}, {"Citation": "Stechschulte L.A., Czernik P.J., Rotter Z.C., Tausif F.N., Corzo C.A., Marciano D.P., Asteian A., Zheng J., Bruning J.B., Kamenecka T.M., et al. PPARG Post-translational Modifications Regulate Bone Formation and Bone Resorption. EBioMedicine. 2016;10:174\u2013184. doi: 10.1016/j.ebiom.2016.06.040.", "ArticleIdList": ["10.1016/j.ebiom.2016.06.040", "PMC5006645", "27422345"]}, {"Citation": "Dragojevi\u010d J., Ostanek B., Mencej-Bedra\u010d S., Komadina R., Pre\u017eelj J., Marc J. PPARG gene promoter polymorphism is associated with non-traumatic hip fracture risk in the elderly Slovenian population: A pilot study. Clin. Biochem. 2011;44:1085\u20131089. doi: 10.1016/j.clinbiochem.2011.06.981.", "ArticleIdList": ["10.1016/j.clinbiochem.2011.06.981", "21756892"]}, {"Citation": "Witkowska-Zimny M., Wr\u00f3bel E. The most important transcriptional factors of osteoblastogenesis. Adv. Cell Biol. 2009;36:695\u2013705. doi: 10.2478/v10052-010-0002-x.", "ArticleIdList": ["10.2478/v10052-010-0002-x"]}, {"Citation": "Reza-L\u00f3pez S.A., Gonz\u00e1lez-Gurrola S., Morales-Morales O.O., Moreno-Gonz\u00e1lez J.G., Rivas-G\u00f3mez A.M., Gonz\u00e1lez-Rodr\u00edguez E., Moreno-Brito V., Lic\u00f3n-Trillo A., Leal-Berumen I. Metabolic Biomarkers in Adults with Type 2 Diabetes: The Role of PPAR-\u03b32 and PPAR-\u03b2/\u03b4 Polymorphisms. Biomolecules. 2023;13:1791. doi: 10.3390/biom13121791.", "ArticleIdList": ["10.3390/biom13121791", "PMC10741495", "38136661"]}, {"Citation": "Li S., He C., Nie H., Pang Q., Wang R., Zeng Z., Song Y. G Allele of the rs1801282 Polymorphism in PPAR\u03b3 Gene Confers an Increased Risk of Obesity and Hypercholesterolemia, While T Allele of the rs3856806 Polymorphism Displays a Protective Role Against Dyslipidemia: A Systematic Review and Meta-Analysis. Front. Endocrinol. 2022;29:919087. doi: 10.3389/fendo.2022.919087.", "ArticleIdList": ["10.3389/fendo.2022.919087", "PMC9276935", "35846293"]}, {"Citation": "Desvergne B., Wahli W. Peroxisome proliferators-activated receptors: Nuclear control of metabolism. Endocr. Rev. 1999;20:649\u2013688.", "ArticleIdList": ["10529898"]}, {"Citation": "Thomas T., Gori F. Leptin acts on human marrow stromal cells to enhance differentiation to osteoblasts and to inhibit differentiation to adipocytes. Endocrinology. 1999;140:1630\u20131638. doi: 10.1210/endo.140.4.6637.", "ArticleIdList": ["10.1210/endo.140.4.6637", "10098497"]}, {"Citation": "Akune T., Ohba S. PPARgamma insufficiency enhances osteogenesis through osteoblast formation from bone marrow progenitors. J. Clin. Investig. 2004;113:846\u2013855. doi: 10.1172/JCI200419900.", "ArticleIdList": ["10.1172/JCI200419900", "PMC362117", "15067317"]}, {"Citation": "Mbalaviele G., Abu-Amer Y. Activation of peroxisome proliferator-activated receptor-gamma pathway inhibits osteoclast differentiation. J. Biol. Chem. 2000;275:14388\u201314393. doi: 10.1074/jbc.275.19.14388.", "ArticleIdList": ["10.1074/jbc.275.19.14388", "10799521"]}, {"Citation": "Simonet W.S., Lacey D.L. Osteoprotegerin: A novel secreted protein involved in the regulation of bone density. Cell. 1997;89:309\u2013319. doi: 10.1016/S0092-8674(00)80209-3.", "ArticleIdList": ["10.1016/S0092-8674(00)80209-3", "9108485"]}, {"Citation": "Yasuda H., Shima N. Identity of osteoclastogenesis inhibitory factor (OCIF) and osteoprotegerin (OPG): A mechanism by which OPG/OCIF inhibits osteoclastogenesis in vitro. Endocrinology. 1998;39:1329\u20131337. doi: 10.1210/endo.139.3.5837.", "ArticleIdList": ["10.1210/endo.139.3.5837", "9492069"]}, {"Citation": "Woo K.M., Choi Y. Osteoprotegerin is present on the membrane of osteoclasts isolated from mouse long bones. Exp. Mol. Med. 2002;34:347\u2013352. doi: 10.1038/emm.2002.49.", "ArticleIdList": ["10.1038/emm.2002.49", "12526098"]}, {"Citation": "Chae G.N., Kwak S.J. NF-kappaB is involved in the TNF-alpha induced inhibition of the differentiation of 3T3-L1 cells by reducing PPARgamma expression. Exp. Mol. Med. 2003;35:431\u2013437. doi: 10.1038/emm.2003.56.", "ArticleIdList": ["10.1038/emm.2003.56", "14646597"]}, {"Citation": "Rhee E.J., Oh K.W., Yun E.J., Jung C.H., Park C.Y., Lee W.Y., Oh E.S., Baek K.H., Kang M.I., Park S.W., et al. The association of Pro12Ala polymorphism of peroxisome proliferator-activated receptor-\u03b3 gene with serum osteoprotegerin levels in healthy Korean women. Exp. Mol. Med. 2007;39:696\u2013704. doi: 10.1038/emm.2007.76.", "ArticleIdList": ["10.1038/emm.2007.76", "18160840"]}, {"Citation": "Lecka-Czernik B., Khan M.P., Letson J., Baroi S., Chougule A. Regulatory Effect of Osteocytes on Extramedullary and Bone Marrow Adipose Tissue Development and Function. Curr. Osteoporos. Rep. 2024;16:301\u2013307. doi: 10.1007/s11914-024-00871-5.", "ArticleIdList": ["10.1007/s11914-024-00871-5", "PMC11186862", "38625510"]}, {"Citation": "Liu S.Z., Yan H., Hou W.K., Xu P., Tian J., Tian L.F., Zhu B.F., Ma J., Lu S.M. Relationships between endothelial nitric oxide synthase gene polymorphisms and osteoporosis in postmenopausal women. J. Zhejiang Univ. Sci. B. 2009;10:609\u2013618. doi: 10.1631/jzus.B0920137.", "ArticleIdList": ["10.1631/jzus.B0920137", "PMC2722703", "19650200"]}, {"Citation": "Johnson M.G., Konicke K. Endothelin signaling regulates mineralization and posttranscriptionally regulates SOST in TMOb cells via miR 126-3p. Physiol. Rep. 2017;5:5. doi: 10.14814/phy2.13088.", "ArticleIdList": ["10.14814/phy2.13088", "PMC5328763", "28235973"]}, {"Citation": "Johnson M.G., Kristianto J. Big endothelin changes the cellular miRNA environment in TMOb osteoblasts and increases mineralization. Connect. Tissue Res. 2014;55:113\u2013116. doi: 10.3109/03008207.2014.923866.", "ArticleIdList": ["10.3109/03008207.2014.923866", "PMC4640685", "25158193"]}]}], "History": [{"Year": "2024", "Month": "5", "Day": "16"}, {"Year": "2024", "Month": "6", "Day": "3"}, {"Year": "2024", "Month": "6", "Day": "21"}, {"Year": "2024", "Month": "7", "Day": "27", "Hour": "10", "Minute": "47"}, {"Year": "2024", "Month": "7", "Day": "27", "Hour": "10", "Minute": "46"}, {"Year": "2024", "Month": "7", "Day": "27", "Hour": "1", "Minute": "6"}, {"Year": "2024", "Month": "6", "Day": "27"}], "PublicationStatus": "epublish", "ArticleIdList": ["39062013", "PMC11274254", "10.3390/biomedicines12071440", "biomedicines12071440"]}}]}